$INTC
Intel Corp Stock $intc

$intc Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000005086321000018 Filed on April 23, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$19.67B	$19.83B
YoY Change	-0.78%	23.45%
Cost Of Revenue	$8.819B	$7.812B
YoY Change	12.89%	12.05%
Gross Profit	$10.85B	$12.02B
YoY Change	-9.67%	32.2%
Gross Profit Margin	55.17%	60.6%
Selling, General & Admin	$1.328B	$1.541B
YoY Change	-13.82%	-2.65%
% of Gross Profit	12.24%	12.82%
Research & Development	$3.623B	$3.275B
YoY Change	10.63%	-1.71%
% of Gross Profit	33.38%	27.26%
Depreciation & Amortization	$2.454B	$2.623B
YoY Change	-6.44%	17.68%
% of Gross Profit	22.61%	21.83%
Operating Expenses	$7.160B	$4.978B
YoY Change	43.83%	1.28%
Operating Profit	$3.694B	$7.038B
YoY Change	-47.51%	68.62%
Interest Expense	$190.0M	$135.0M
YoY Change	40.74%	-2.17%
% of Operating Profit	5.14%	1.92%
Other Income/Expense, Net	-$156.0M	-$313.0M
YoY Change	-50.16%	413.11%
Pretax Income	$3.906B	$6.614B
YoY Change	-40.94%	45.46%
Income Tax	$545.0M	$953.0M
% Of Pretax Income	13.95%	14.41%
Net Earnings	$3.361B	$5.661B
YoY Change	-40.63%	42.45%
Net Earnings / Revenue	17.08%	28.55%
Basic Earnings Per Share	$0.83	$1.33
Diluted Earnings Per Share	$0.82	$1.31
COMMON SHARES
Basic Shares Outstanding	4.056B shares	4.266B shares
Diluted Shares Outstanding	4.096B shares	4.312B shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.609B	$12.68B
YoY Change	-39.97%	116.61%
Cash & Equivalents	$5.192B	$11.38B
Short-Term Investments	$2.417B	$1.296B
Other Short-Term Assets	$2.124B	$2.997B
YoY Change	-29.13%	30.02%
Inventory	$8.487B	$9.246B
Prepaid Expenses
Receivables	$7.208B	$8.455B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$45.77B	$41.50B
YoY Change	10.29%	42.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$57.33B	$56.77B
YoY Change	0.99%	13.45%
Goodwill	$26.97B	$26.28B
YoY Change	2.64%	7.16%
Intangibles	$8.408B	$10.43B
YoY Change	-19.38%	-8.97%
Long-Term Investments	$17.00M	$28.00M
YoY Change	-39.29%	-98.22%
Other Assets	$5.327B	$5.911B
YoY Change	-9.88%	4.42%
Total Long-Term Assets	$104.8B	$106.2B
YoY Change	-1.28%	5.79%
TOTAL ASSETS
Total Short-Term Assets	$45.77B	$41.50B
Total Long-Term Assets	$104.8B	$106.2B
Total Assets	$150.6B	$147.7B
YoY Change	1.97%	14.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.434B	$4.638B
YoY Change	17.16%	14.26%
Accrued Expenses	$16.07B	$12.89B
YoY Change	24.63%	11.41%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.647B	$3.464B
YoY Change	-23.59%	25.96%
Total Short-Term Liabilities	$24.15B	$23.90B
YoY Change	1.07%	26.36%
LONG-TERM LIABILITIES
Long-Term Debt	$33.24B	$36.46B
YoY Change	-8.83%	41.64%
Other Long-Term Liabilities	$5.322B	$2.975B
YoY Change	78.89%	6.36%
Total Long-Term Liabilities	$38.56B	$39.43B
YoY Change	-2.21%	38.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.15B	$23.90B
Total Long-Term Liabilities	$38.56B	$39.43B
Total Liabilities	$62.71B	$63.33B
YoY Change	-0.97%	33.47%
SHAREHOLDERS EQUITY
Retained Earnings	$54.64B	$52.64B
YoY Change	3.79%	7.16%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$79.81B	$76.35B
YoY Change
Total Liabilities & Shareholders Equity	$150.6B	$147.7B
YoY Change	1.97%	14.1%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$3.361B	$5.661B
YoY Change	-40.63%	42.45%
Depreciation, Depletion And Amortization	$2.454B	$2.623B
YoY Change	-6.44%	17.68%
Cash From Operating Activities	$5.348B	$6.158B
YoY Change	-13.15%	24.18%
INVESTING ACTIVITIES
Capital Expenditures	$3.972B	$3.268B
YoY Change	21.54%	-1.6%
Acquisitions
YoY Change
Other Investing Activities	-$866.0M	$343.0M
YoY Change	-352.48%	43.51%
Cash From Investing Activities	-$2.001B	-$3.736B
YoY Change	-46.44%	37.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$2.301B	$4.229B
YoY Change	-45.59%	67.15%
Debt Paid & Issued, Net	$0.00	$1.075B
YoY Change	-100.0%	24.85%
Cash From Financing Activities	-$4.020B	$4.764B
YoY Change	-184.38%	-326.64%
NET CHANGE
Cash From Operating Activities	$5.348B	$6.158B
Cash From Investing Activities	-$2.001B	-$3.736B
Cash From Financing Activities	-$4.020B	$4.764B
Net Change In Cash	-$673.0M	$7.186B
YoY Change	-109.37%	5222.96%
FREE CASH FLOW
Cash From Operating Activities	$5.348B	$6.158B
Capital Expenditures	$3.972B	$3.268B
Free Cash Flow	$1.376B	$2.890B
YoY Change	-52.39%	76.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-27
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000050863
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-25
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	79778000000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	77645000000	USD
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4038000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4062000000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4038000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4062000000	shares
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-27
CY2021Q1	us-gaap	Inventory Net InventoryNet	8487000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	8427000000	USD
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	000-06217
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	INTEL CORPORATION
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-1672743
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2200 Mission College Boulevard,
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Clara,
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95054-1549
CY2021Q1	dei	City Area Code CityAreaCode	(408)
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	765-8080
CY2021Q1	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value
CY2021Q1	dei	Trading Symbol TradingSymbol	INTC
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4038000000	shares
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19673000000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19828000000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8819000000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7812000000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	10854000000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	12016000000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3623000000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3275000000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1328000000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1541000000	USD
CY2021Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	2209000000	USD
CY2020Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	162000000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	7160000000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4056000000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4266000000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4096000000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4312000000	shares
CY2020Q4	us-gaap	Trading Securities TradingSecurities	15738000000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	4978000000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3694000000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7038000000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	368000000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-111000000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-156000000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-313000000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3906000000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6614000000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	545000000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	953000000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	5661000000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.83
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.82
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.31
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	5661000000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-350000000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-268000000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-13000000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-12000000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-15000000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-5000000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-352000000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-261000000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3009000000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5400000000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5192000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5865000000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2417000000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2292000000	USD
CY2021Q1	us-gaap	Trading Securities TradingSecurities	14788000000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7208000000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6782000000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5327000000	USD
CY2021Q1	intc	Assets Held For Sale AssetsHeldForSale	5557000000	USD
CY2020Q4	intc	Assets Held For Sale AssetsHeldForSale	5400000000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2124000000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2745000000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	45773000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	47249000000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57330000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	56584000000	USD
CY2021Q1	intc	Equity Investments EquityInvestments	5404000000	USD
CY2020Q4	intc	Equity Investments EquityInvestments	5152000000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	1409000000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	2192000000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	26971000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	26971000000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8408000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9026000000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5917000000	USD
CY2021Q1	us-gaap	Assets Assets	150622000000	USD
CY2020Q4	us-gaap	Assets Assets	153091000000	USD
CY2021Q1	us-gaap	Debt Current DebtCurrent	2647000000	USD
CY2020Q4	us-gaap	Debt Current DebtCurrent	2504000000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5434000000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5581000000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2757000000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3999000000	USD
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	13313000000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12670000000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	24151000000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24754000000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	33237000000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	33897000000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	90000000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5322000000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1367000000	USD
CY2021Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	4605000000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	4578000000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3410000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3843000000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3614000000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	26272000000	USD
CY2020Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	25556000000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1103000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-751000000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	54638000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	56233000000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	79807000000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	81038000000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	150622000000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	153091000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5865000000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4194000000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	5661000000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	2454000000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	2623000000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	425000000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	449000000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	2209000000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	162000000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	448000000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	427000000	USD
CY2021Q1	intc	Non Cash Gains Losses On Equity Investments Net NonCashGainsLossesOnEquityInvestmentsNet	299000000	USD
CY2020Q1	intc	Non Cash Gains Losses On Equity Investments Net NonCashGainsLossesOnEquityInvestmentsNet	-134000000	USD
CY2020Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	497000000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5548000000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6158000000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	426000000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	796000000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-180000000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	548000000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	303000000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	117000000	USD
CY2021Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1283000000	USD
CY2020Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1605000000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1566000000	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-87000000	USD
CY2021Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	383000000	USD
CY2020Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	753000000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	641000000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1132000000	USD
CY2021Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	2187000000	USD
CY2021Q1	intc	Divestiture Additions To Property Plant And Equipment Held For Sale DivestitureAdditionsToPropertyPlantAndEquipmentHeldForSale	416000000	USD
CY2020Q1	intc	Divestiture Additions To Property Plant And Equipment Held For Sale DivestitureAdditionsToPropertyPlantAndEquipmentHeldForSale	0	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	593000000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3972000000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3268000000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	513000000	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1232000000	USD
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	625000000	USD
CY2021Q1	us-gaap	Payments To Acquire Trading Securities Heldforinvestment PaymentsToAcquireTradingSecuritiesHeldforinvestment	5981000000	USD
CY2020Q1	us-gaap	Payments To Acquire Trading Securities Heldforinvestment PaymentsToAcquireTradingSecuritiesHeldforinvestment	3897000000	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment	6777000000	USD
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment	3660000000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-406000000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	343000000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2547000000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3736000000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	10247000000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1075000000	USD
CY2021Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	565000000	USD
CY2020Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	503000000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2301000000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4229000000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1411000000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1408000000	USD
CY2021Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-527000000	USD
CY2020Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	726000000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3674000000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4764000000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-673000000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7186000000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5192000000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11380000000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2472000000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2294000000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	161000000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	67000000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	172000000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	211000000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	3361000000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-352000000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	565000000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	425000000	USD
CY2021Q1	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	0	USD
CY2021Q1	us-gaap	Temporary Equity Issue Period Increase Or Decrease TemporaryEquityIssuePeriodIncreaseOrDecrease	0	USD
CY2021Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2415000000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	29000000	USD
CY2021Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2821000000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	79807000000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	77504000000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	5661000000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-261000000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	620000000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	449000000	USD
CY2020Q1	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	155000000	USD
CY2020Q1	us-gaap	Temporary Equity Issue Period Increase Or Decrease TemporaryEquityIssuePeriodIncreaseOrDecrease	-750000000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4109000000	USD
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	96000000	USD
CY2020Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2819000000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	76354000000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.83
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19673000000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19828000000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3694000000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7038000000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19673000000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19828000000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	5661000000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4056000000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4266000000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	40000000	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	46000000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4096000000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4312000000	shares
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.82
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.31
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	396000000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1900000000	USD
CY2020Q4	intc	Contract With Customer Liability Contract Termination ContractWithCustomerLiabilityContractTermination	1600000000	USD
CY2021Q1	intc	Contract With Customer Liability Concession Payments ContractWithCustomerLiabilityConcessionPayments	950000000	USD
CY2021Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	926000000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	908000000	USD
CY2021Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5758000000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5693000000	USD
CY2021Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1803000000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1826000000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	8487000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	8427000000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	37000000	USD
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	93000000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	190000000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	135000000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-271000000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-156000000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-313000000	USD
CY2021Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	97000000	USD
CY2020Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	83000000	USD
CY2021Q1	us-gaap	Severance Costs1 SeveranceCosts1	6000000	USD
CY2021Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	38000000	USD
CY2020Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	143000000	USD
CY2021Q1	intc	Other Net Equity Investments OtherNetEquityInvestments	146000000	USD
CY2020Q1	intc	Other Net Equity Investments OtherNetEquityInvestments	56000000	USD
CY2020Q1	us-gaap	Severance Costs1 SeveranceCosts1	105000000	USD
CY2021Q1	intc	Litigation Charges And Other LitigationChargesAndOther	2203000000	USD
CY2020Q1	intc	Litigation Charges And Other LitigationChargesAndOther	57000000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	2209000000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	162000000	USD
CY2021Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2200000000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	7000000000.0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	7800000000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue	3596000000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	341000000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1068000000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	0	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	2130000000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	7135000000	USD
CY2021Q1	us-gaap	Marketable Securities MarketableSecurities	1523000000	USD
CY2020Q4	us-gaap	Marketable Securities MarketableSecurities	1830000000	USD
CY2021Q1	us-gaap	Cost Method Investments CostMethodInvestments	3864000000	USD
CY2020Q4	us-gaap	Cost Method Investments CostMethodInvestments	3304000000	USD
CY2021Q1	us-gaap	Equity Method Investments EquityMethodInvestments	17000000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	18000000	USD
CY2021Q1	intc	Equity Investments EquityInvestments	5404000000	USD
CY2020Q4	intc	Equity Investments EquityInvestments	5152000000	USD
CY2021Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-291000000	USD
CY2020Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-103000000	USD
CY2021Q1	intc	Observablepriceadjustmentsonnonmarketable Observablepriceadjustmentsonnonmarketable	551000000	USD
CY2020Q1	intc	Observablepriceadjustmentsonnonmarketable Observablepriceadjustmentsonnonmarketable	79000000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	368000000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-111000000	USD
CY2021Q1	intc	Equity Securities Fvni Gain Loss Net EquitySecuritiesFVNIGainLossNet	311000000	USD
CY2020Q1	intc	Equity Securities Fvni Gain Loss Net EquitySecuritiesFVNIGainLossNet	-140000000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-85000000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-7000000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	226000000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-147000000	USD
CY2020Q4	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	9000000000.0	USD
CY2021Q1	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	723000000	USD
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	962000000	USD
CY2021Q1	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Current DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent	4759000000	USD
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Current DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent	4363000000	USD
CY2021Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	5482000000	USD
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	5325000000	USD
CY2021Q1	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	127000000	USD
CY2021Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	48044000000	USD
CY2020Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	47696000000	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1455000000	USD
CY2021Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability		USD
CY2021Q1	us-gaap	Derivative Assets DerivativeAssets	1455000000	USD
CY2021Q1	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	404000000	USD
CY2021Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	1036000000	USD
CY2021Q1	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	15000000	USD
CY2021Q1	us-gaap	Securities Purchased Under Agreements To Resell Gross SecuritiesPurchasedUnderAgreementsToResellGross	1350000000	USD
CY2021Q1	us-gaap	Securities Purchased Under Agreements To Resell Liability SecuritiesPurchasedUnderAgreementsToResellLiability	0	USD
CY2021Q1	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	1350000000	USD
CY2021Q1	us-gaap	Securities Purchased Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesPurchasedUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	USD
CY2021Q1	us-gaap	Securities Purchased Under Agreements To Resell Collateral Obligation To Return Securities SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnSecurities	1350000000	USD
CY2021Q1	us-gaap	Securities Purchased Under Agreements To Resell Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesPurchasedUnderAgreementsToResellOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2021Q1	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Gross DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedGross	2805000000	USD
CY2021Q1	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability	0	USD
CY2021Q1	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed	2805000000	USD
CY2021Q1	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Not Offset Policy Election Deduction DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedNotOffsetPolicyElectionDeduction	404000000	USD
CY2021Q1	intc	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Collateral Obligation To Return Cash Or Non Cash DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnCashOrNonCash	2386000000	USD
CY2021Q1	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	15000000	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	516000000	USD
CY2021Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	516000000	USD
CY2021Q1	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	404000000	USD
CY2021Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	112000000	USD
CY2021Q1	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	516000000	USD
CY2021Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	516000000	USD
CY2021Q1	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	404000000	USD
CY2021Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	112000000	USD
CY2021Q1	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	2235000000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	2235000000	USD
CY2020Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	264000000	USD
CY2020Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	1904000000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	67000000	USD
CY2020Q4	us-gaap	Securities Purchased Under Agreements To Resell Gross SecuritiesPurchasedUnderAgreementsToResellGross	1900000000	USD
CY2020Q4	us-gaap	Securities Purchased Under Agreements To Resell Liability SecuritiesPurchasedUnderAgreementsToResellLiability	0	USD
CY2020Q4	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	1900000000	USD
CY2020Q4	us-gaap	Securities Purchased Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesPurchasedUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	USD
CY2020Q4	us-gaap	Securities Purchased Under Agreements To Resell Collateral Obligation To Return Securities SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnSecurities	1900000000	USD
CY2020Q4	us-gaap	Securities Purchased Under Agreements To Resell Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesPurchasedUnderAgreementsToResellOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2020Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Gross DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedGross	4135000000	USD
CY2020Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability	0	USD
CY2020Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed	4135000000	USD
CY2020Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Not Offset Policy Election Deduction DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedNotOffsetPolicyElectionDeduction	264000000	USD
CY2020Q4	intc	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Collateral Obligation To Return Cash Or Non Cash DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnCashOrNonCash	3804000000	USD
CY2020Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	67000000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	711000000	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	711000000	USD
CY2020Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	264000000	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	447000000	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	711000000	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	711000000	USD
CY2020Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	264000000	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	447000000	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2021Q1	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	512000000	USD
CY2020Q1	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	-954000000	USD
CY2021Q1	intc	Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge	0	USD
CY2020Q1	intc	Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge	0	USD
CY2021Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="margin-bottom:6pt;margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.562%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#0068b5;border-bottom:1pt solid #0068b5;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Note 13 : </span></td><td colspan="3" style="border-bottom:1pt solid #0068b5;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Contingencies</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a party to various legal proceedings, including those noted in this section. In the first quarter of 2021, we accrued a charge of $2.2 billion related to litigation involving VLSI, described below. Excluding this charge, management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends; however, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could include substantial monetary damages. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">European Commission Competition Matter</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2001, the EC commenced an investigation regarding claims by Advanced Micro Devices, Inc. (AMD) that we used unfair business practices to persuade customers to buy our microprocessors. We received numerous requests for information and documents from the EC and we responded to each of those requests. The EC issued a Statement of Objections in July 2007 and held a hearing on that Statement in March 2008. The EC issued a Supplemental Statement of Objections in July 2008. In May 2009, the EC issued a decision finding that we had violated Article 82 of the EC Treaty and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 (later renumbered as Article 102 by a new treaty) by offering alleged "conditional rebates and payments" that required our customers to purchase all or most of their x86 microprocessors from us. The EC also found that we violated Article 82 by making alleged "payments to prevent sales of specific rival products." The EC imposed a fine in the amount of €1.1 billion ($1.4 billion as of May 2009), which we subsequently paid during the third quarter of 2009, and ordered us to "immediately bring to an end the infringement referred to in" the EC decision.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The EC decision contained no specific direction on whether or how we should modify our business practices. Instead, the decision stated that we should "cease and desist" from further conduct that, in the EC's opinion, would violate applicable law. We took steps, which are subject to the EC's ongoing review, to comply with that decision pending appeal. We had discussions with the EC to better understand the decision and to explain changes to our business practices.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We appealed the EC decision to the Court of First Instance (which has been renamed the General Court) in July 2009. The hearing of our appeal took place in July 2012. In June 2014, the General Court rejected our appeal in its entirety. In August 2014, we filed an appeal with the European Court of Justice. In November 2014, Intervener Association for Competitive Technologies filed comments in support of Intel’s grounds of appeal. The EC and interveners filed briefs in November 2014, we filed a reply in February 2015, and the EC filed a rejoinder in April 2015. The Court of Justice held oral argument in June 2016. In October 2016, Advocate General Wahl, an advisor to the Court of Justice, issued a non-binding advisory opinion that favored Intel on a number of grounds. The Court of Justice issued its decision in September 2017, setting aside the judgment of the General Court and sending the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. The General Court has appointed a panel of five judges to consider our appeal of the EC’s 2009 decision in light of the Court of Justice’s clarifications of the law. In November 2017, the parties filed initial “Observations” about the Court of Justice’s decision and the appeal and were invited by the General Court to offer supplemental comments to each other’s “Observations,” which the parties submitted in March 2018. Responses to other questions posed by the General Court were filed in May and June 2018. The General Court heard oral argument in March 2020. Pending the final decision in this matter, the fine paid by Intel has been placed by the EC in commercial bank accounts where it accrues interest.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation Related to Security Vulnerabilities</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2017, a Google research team notified us and other companies that it had identified security vulnerabilities (now commonly referred to as “Spectre” and “Meltdown”) that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. On January 3, 2018, information on the security vulnerabilities was publicly reported, before software and firmware updates to address the vulnerabilities were made widely available. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Numerous lawsuits have been filed against Intel and, in certain cases, our current and former executives and directors, in U.S. federal and state courts and in certain courts in other countries relating to the Spectre and Meltdown security vulnerabilities, as well as other variants of these vulnerabilities that have since been identified.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of April 21, 2021, consumer class action lawsuits relating to the above class of security vulnerabilities publicly disclosed since 2018 were pending in the United States, Canada, and Israel. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by Intel's actions and/or omissions in connection with the security vulnerabilities and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the United States, numerous individual class action suits filed in various jurisdictions were consolidated in April 2018 for all pretrial proceedings in the U.S. District Court for the District of Oregon. In March 2020, the court granted Intel's motion to dismiss the complaint in that consolidated action but granted plaintiffs leave to amend. In March 2021, the court granted Intel’s motion to dismiss that amended complaint, but granted plaintiffs leave to further amend in part. In Canada, in one case pending in the Superior Court of Justice of Ontario, an initial status conference has not yet been scheduled. In a second case pending in the Superior Court of Justice of Quebec, a stay of the case is in effect until July 2021. In Israel, two consumer class action lawsuits were filed in the District Court of Haifa. In the first case, the District Court denied the parties' joint motion to stay filed in January 2019, but to date has deferred Intel's deadline to respond to the complaint. Intel filed a motion to stay the second case pending resolution of the consolidated proceeding in the United States, and a hearing on that motion has been scheduled for October 2021. Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. We dispute the pending claims described above and intend to defend those lawsuits vigorously. Given the procedural posture and the nature of those cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from those matters.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to these lawsuits, Intel stockholders filed multiple shareholder derivative lawsuits since January 2018 against certain current and former members of our Board of Directors and certain current and former officers, alleging that the defendants breached their duties to Intel in connection with the disclosure of the security vulnerabilities and the failure to take action in relation to alleged insider trading. The complaints sought to recover damages from the defendants on behalf of Intel. Some of the derivative actions were filed in the U.S. District Court for the Northern District of California and were consolidated, and the others were filed in the Superior Court of the State of California in San Mateo County and were consolidated. The federal court granted defendants' motion to dismiss in August 2018 on the ground that plaintiffs failed to plead facts sufficient to show they were excused from making a pre-lawsuit demand on the Board. The federal court granted plaintiffs leave to amend their complaint, but subsequently dismissed the cases in January 2019 at plaintiffs' request. The California Superior Court entered judgment in defendants' favor in August 2020 after granting defendants' motions to dismiss plaintiffs' consolidated complaint and three successive amended complaints, all for failure to plead facts sufficient to show plaintiffs were excused from making pre-lawsuit demand on the Board. Plaintiffs filed a notice of appeal of the California court's judgment in October 2020.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2021, another Intel stockholder filed a derivative lawsuit in the Superior Court in San Mateo County against certain current and former officers and members of our Board of Directors. The lawsuit asserts claims similar to those dismissed in August 2020, except that it alleges that the stockholder made a pre-lawsuit demand on our Board of Directors and that the demand was wrongfully refused. Defendants moved to dismiss or stay the action in March 2021, because Intel’s bylaws require such claims to be brought in Delaware. </span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Institute of Microelectronics, Chinese Academy of Sciences v. Intel China, Ltd., et al.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2018, the Institute of Microelectronics of the Chinese Academy of Sciences (IMECAS) sued Intel China, Ltd., Dell China, Ltd. (Dell), and Beijing JingDong Century Information Technology, Ltd. (JD) for patent infringement in the Beijing High Court. IMECAS alleges that Intel’s Core series processors infringe Chinese patent CN 102956457 (’457 Patent). The complaint demands an injunction and damages of at least RMB 200,000,000 plus the cost of litigation. A trial date is not yet set. In March 2018, Dell tendered indemnity to Intel, which Intel granted in April 2018. JD also tendered indemnity to Intel, which Intel granted in October 2018. In March 2018, Intel filed an invalidation request on the ‘457 patent with the Chinese Patent Review Board (PRB). The PRB held an oral hearing in September 2018 and in February 2019 upheld the validity of the challenged claims. Intel filed a complaint in April 2019 with the Beijing Intellectual Property Court challenging the February 2019 PRB ruling. In January 2020, Intel filed a second invalidation request on the ‘457 patent with the PRB, for which the PRB heard oral argument in July 2020 and in November 2020 held the challenged apparatus claims invalid. IMECAS filed a complaint in February 2021 with the Beijing Intellectual Property Court challenging the November 2020 PRB ruling. In December 2020, Intel filed a third invalidation request on the ’457 patent with the PRB.  A hearing on Intel’s third PRB invalidation request on the ’457 patent is scheduled for May 2021. In September 2018 and March 2019, Intel filed petitions with the U. S. Patent & Trademark Office (USPTO) requesting institution of </span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> review (IPR) of U.S. Patent No. 9,070,719, the U.S. counterpart to the ‘457 patent. The USPTO denied institution of Intel’s petitions in March and October 2019, respectively. In April 2019, Intel filed a request for rehearing and a petition for a Precedential Opinion Panel (POP) in the USPTO to challenge the denial of its first IPR petition, and in November 2019 Intel filed a request for rehearing on the second IPR petition. In January 2020, the USPTO denied the POP petition on the first IPR petition. In June 2020, the Patent Trial and Appeal Board denied Intel's rehearing requests on both petitions.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2019, IMECAS filed second and third lawsuits, in the Beijing IP Court, alleging infringement of Chinese Patent No. CN 102386226 (‘226 Patent) based on the manufacturing and sale of Intel’s Core i3 microprocessors. Defendants in the second case are Lenovo (Beijing) Co., Ltd. (Lenovo) and Beijing Jiayun Huitong Technology Development Co. Ltd. (BJHT). Defendants in the third case are Intel Corp., Intel China Co., Ltd., the Intel China Beijing Branch, Beijing Digital China Co., Ltd. (Digital China), and JD. Both complaints demand injunctions plus litigation costs and reserve the right to claim damages in unspecified amounts. No proceedings have occurred or are yet scheduled in these lawsuits. In December 2019, Lenovo tendered indemnity to Intel, which Intel granted in March 2020. In July 2020, Intel filed two invalidation requests on the '226 patent with the Chinese PRB. The PRB heard oral argument in December 2020, during which IMECAS proposed amendments to two claims. The PRB ruled in April 2021 on both invalidation requests, finding the two amended claims as well as the unamended claims not invalid. Given the procedural posture and the nature of these cases, the unspecified nature and extent of damages claimed by IMECAS, and uncertainty regarding the availability of injunctive relief under applicable law, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters. We dispute IMECAS’s claims and intend to vigorously defend against them.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VLSI Technology LLC v. Intel</span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2017, VLSI filed a complaint against Intel in the U.S. District Court for the Northern District of California alleging infringement of eight patents acquired from NXP Semiconductors, N.V. (NXP). The patents, which originated at Freescale Semiconductor, Inc. and NXP B.V., are U.S. Patent Nos. 7,268,588; 7,675,806; 7,706,207; 7,709,303; 8,004,922; 8,020,014; 8,268,672; and 8,566,836. VLSI accuses various FPGA and processor products of infringement. VLSI estimated its damages to be as high as $7.1 billion, and its complaint further sought enhanced damages, future royalties, attorneys’ fees, costs, and interest. In May, June, September, and October 2018, Intel filed IPR petitions challenging the patentability of certain claims in all eight of the patents in-suit. The PTAB instituted review of six patents and denied institution on two patents. As a result of the institution decisions, the parties stipulated to stay the District Court action in March 2019. In December 2019 and February 2020, the PTAB found all claims of the '588 and '303 patents, and some claims of the '922 patent, to be unpatentable. The PTAB found the challenged claims of the '014, '672, and '207 patents to be patentable. Intel moved for a continuation of the stay in March 2020 as it appealed certain rulings by the PTAB. In June 2020, the District Court issued an order continuing the stay through August 2021 and setting trial for December 2022. The Federal Circuit has thus far affirmed the PTAB’s decisions as to the ‘207 and ‘672 patents.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2018, VLSI filed a second suit against Intel, in U.S. District Court for the District of Delaware, alleging infringement by various Intel processors of five additional patents acquired from NXP: U.S. Patent Nos. 6,212,663; 7,246,027; 7,247,552; 7,523,331; and 8,081,026. VLSI accused Intel of willful infringement and seeks an injunction or, in the alternative, ongoing royalties, enhanced damages, attorneys’ fees and costs, and interest. In March 2019, the District Court dismissed VLSI’s claims for willful infringement as to all the patents-in-suit except the ‘027 patent, and also dismissed VLSI’s allegations of indirect infringement as to the ‘633, ‘331, and ‘026 patents. In June 2019, Intel filed requests for </span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> review of the patentability of claims in all five patents-in-suit. In January 2020, the District Court vacated the November 2020 trial date based on agreement of the parties; no trial date is currently set. In January and February 2020, the PTAB instituted review of the '552, '633, '331, and '026 patents and as a result Intel moved for stay of the District Court proceedings. In May 2020, the District Court stayed the case as to the '026 and '552 patents but allowed the case to proceed on the '027 and '331 patents. In January 2021, the PTAB invalidated certain asserted claims of the ‘026 patent, and in February the PTAB invalidated all asserted claims of the ‘552 patent. Intel filed a notice of appeal regarding the PTAB’s decision as to the ‘026 patent in March 2021, and the case remains stayed as to that patent. For the '027 and '331 patents, VLSI is seeking damages of approximately $4.13 billion plus enhanced damages for the '027 patent. VLSI is no longer asserting claims from the '633 patent. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In March 2019, VLSI filed a third suit against Intel, also in U.S. District Court for the District of Delaware, alleging infringement of six more patents acquired from NXP: U.S. Patent Nos. 6,366,522; 6,663,187; 7,292,485; 7,606,983; 7,725,759; and 7,793,025. In April 2019, VLSI voluntarily dismissed this Delaware case without prejudice. In April 2019, VLSI filed three new infringement suits against Intel in the U.S. District Court for the Western District of Texas (WDTX) accusing various Intel processors of infringement. The three suits collectively assert the same six patents from the voluntarily dismissed Delaware case plus two additional patents acquired from NXP, U.S. Patent Nos. 7,523,373 and 8,156,357. VLSI accuses Intel of willful infringement and seeks an injunction or, in the alternative, ongoing royalties, enhanced damages, attorneys’ fees and costs, and interest. In the first Texas case, VLSI asserted the ‘373 and ‘759 patents (in December 2020 the Court granted Intel summary judgment of non-infringement on the ‘357 patent, which had also been asserted in the first Texas case). That case went to trial in February 2021, and the jury awarded a “lump sum” to VLSI of $1.5 billion for literal infringement of the ‘373 patent and $675 million for infringement under the doctrine of equivalents of the ‘759 patent. The jury found that Intel had not willfully infringed either patent. Intel plans to challenge the verdict in post-trial motions and on appeal. The second Texas case went to trial in April 2021, and the jury found that Intel does not infringe the ‘522 and ‘187 patents. The third case is scheduled for trial on June 7, 2021, and VLSI seeks over $1.9 billion for alleged infringement of the ‘983, ‘025 and ‘485 patents, plus enhanced damages for willful infringement. In October and November 2019, and in February 2020, Intel filed IPR petitions on certain asserted claims across six of the patents-in-suit in WDTX. Between May and October 2020, the PTAB denied all of these requests. Intel requested a rehearing and review from the POP as to all petitions. All requests for POP review were denied in October and December 2020, and all requests for rehearing were denied as to all petitions between December 2020 and February 2021. Intel filed notices of appeal regarding the discretionary denials for all petitions in February and March of 2021, and VLSI moved to dismiss those appeals in March 2021. The Federal Circuit has consolidated the 12 appeals into five separate sets. In each of the first three of the consolidated appeals, the Director of the USPTO has intervened in support of VLSI’s motions to dismiss, and the Director has indicated an intent to intervene in the remaining two. The Federal Circuit has not yet ruled on these issues.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2019, VLSI filed a case in Shenzhen Intermediate People’s Court against Intel, Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserts Chinese Patent 201410094015.9 accusing certain Intel Core processors of infringement. VLSI requests an injunction as well as RMB 1.3 million in damages. Defendants filed an invalidation petition in October 2019 with the PRB, but no hearing date has been set. In May 2020, defendants filed a motion to stay the trial court proceedings pending a determination on invalidity. The court has not yet ruled on the motion to stay. The court held the first evidentiary hearing in November 2020.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2019, VLSI filed a second case in Shanghai Intellectual Property Court against Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserts Chinese Patent 201080024173.7. VLSI accuses certain Intel core processors and seeks an injunction. Defendants filed with the PRB an invalidation petition in October 2019. No hearing date has been set. In June 2020, defendants filed a motion to stay the trial court proceedings pending a determination on invalidity. The court held its first evidentiary hearing in September 2020. The court held a second evidentiary hearing in December 2020. The court stayed the case in December 2020 pending a determination on invalidity by the PRB.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2019, Intel, along with Apple Inc., filed a complaint against Fortress Investment Group LLC, Fortress Credit Co. LLC, Uniloc 2017 LLC, Uniloc USA, Inc., Uniloc Luxembourg S.A.R.L., VLSI, INVT SPE LLC, Inventergy Global, Inc., DSS Technology Management, Inc., IXI IP, LLC, and Seven Networks, LLC. Plaintiffs allege violations of Section 1 of the Sherman Act by certain defendants, Section 7 of the Clayton Act by certain defendants, and California Business and Professions Code section 17200 by all defendants based on defendants' unlawful aggregation of patents. In February 2020, defendants moved to dismiss plaintiffs' complaint. In July 2020, the court granted defendants’ motion to dismiss with leave to amend. The court dismissed antitrust claims related to two DSS patents with prejudice. The plaintiffs filed an amended complaint in August 2020, and defendants moved to dismiss in September 2020. The court heard defendants' motion to dismiss the amended complaint in December 2020 and dismissed plaintiffs’ amended complaint in January 2021, with leave to further amend. In December 2020, the court granted a joint motion by Apple and Seven Networks to dismiss with prejudice Apple’s claims against Seven Networks. Plaintiffs filed a second amended complaint in March 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2020, affiliates controlled by Fortress Investment Group, which also controls VLSI, acquired Finjan Holdings, Inc. Intel had signed a “Settlement, Release and Patent License Agreement” with Finjan in 2012, acquiring a license to the patents of Finjan and its affiliates, current or future, through a capture period of November 20, 2022. The agreement also contains covenants wherein Finjan agrees to cause its affiliates to comply with the agreement. As such, Intel maintains that it now has a license to the patents of VLSI, which has become a Finjan affiliate, and that Finjan must cause VLSI to dismiss its suits against Intel. In August 2020, Intel started dispute resolution proceedings under the agreement. As a part of this dispute resolution process, Intel and Finjan held a mediation in December 2020, but failed to resolve their differences. Intel filed suit to enforce its rights under the License Agreement with Finjan in January 2021 in Delaware Chancery Court. In March 2021, defendants filed motions to dismiss the Chancery Court proceedings. In September 2020, Intel filed motions to stay the Texas, Delaware, and Shanghai matters pending resolution of its dispute with Finjan. In November 2020, Intel filed a motion to stay the Shenzhen matter pending resolution of its dispute with Finjan. In November 2020, the Delaware Court denied Intel’s motion to stay. The other stay motions remain pending. Finally, Intel filed a motion to amend its answer in the Texas matters to add a license defense in November 2020, and filed a motion to amend its answer in the Delaware matter to add a license defense in February 2021. The courts have yet to rule on these motions.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">After consideration of the verdicts in the WDTX cases and the additional pending lawsuits filed by VLSI, Intel accrued a charge of $2.2 billion in the first quarter of 2021. We dispute VLSI’s claims and intend to vigorously defend against them.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation Related to 7nm Product Delay Announcement</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Starting in July 2020, five securities class action lawsuits were filed in the U.S. District Court for the Northern District of California against Intel and certain current and former officers based on Intel’s July 2020 announcement of 7nm product delays. The plaintiffs, who purport to represent classes of acquirers of Intel stock between October 2019 and July 2020, generally allege that the defendants violated securities laws by making false or misleading statements about the timeline for 7nm products in light of subsequently announced delays. In October 2020, the court consolidated the lawsuits and appointed lead plaintiffs, and in January 2021 the lead plaintiffs filed a consolidated complaint. Defendants moved to dismiss the consolidated complaint in March 2021. We dispute the claims described above and intend to defend the lawsuits vigorously. Given the procedural posture and the nature of those cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from those matters.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the securities lawsuits, several Intel stockholders filed derivative lawsuits against certain members of our Board of Directors and certain current and former officers based on Intel’s July 2020 announcement of 7nm product delays. The complaints, which were filed in the U.S. District Court for the District of Delaware in December 2020, alleged that defendants breached their fiduciary duties to Intel by either making or allowing the company to make alleged misstatements about the timeline for 7nm products during the class period alleged in the securities litigation. Certain of the complaints also alleged claims under Section 14(a) of the Securities Exchange Act of 1934. The court consolidated the cases in January 2021, and ordered plaintiffs to file a consolidated complaint by mid-April 2021. In early April 2021, plaintiffs voluntarily dismissed the action.</span></div>

Files In Submission

Name	View Source	Status
0000050863-21-000018-index-headers.html	Edgar Link	pending
0000050863-21-000018-index.html	Edgar Link	pending
0000050863-21-000018.txt	Edgar Link	pending
0000050863-21-000018-xbrl.zip	Edgar Link	pending
a3272021ex103.htm	Edgar Link	pending
a3272021ex104.htm	Edgar Link	pending
a3272021ex105.htm	Edgar Link	pending
a3272021ex106.htm	Edgar Link	pending
a3272021ex107.htm	Edgar Link	pending
a3272021ex108.htm	Edgar Link	pending
a3272021ex109.htm	Edgar Link	pending
a3272021ex311.htm	Edgar Link	pending
a3272021ex312.htm	Edgar Link	pending
a3272021ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
intc-20210327.htm	Edgar Link	pending
intc-20210327.xsd	Edgar Link	pending
intc-20210327_cal.xml	Edgar Link	unprocessable
intc-20210327_def.xml	Edgar Link	unprocessable
intc-20210327_g1.jpg	Edgar Link	pending
intc-20210327_g10.jpg	Edgar Link	pending
intc-20210327_g11.jpg	Edgar Link	pending
intc-20210327_g12.jpg	Edgar Link	pending
intc-20210327_g13.jpg	Edgar Link	pending
intc-20210327_g14.jpg	Edgar Link	pending
intc-20210327_g15.jpg	Edgar Link	pending
intc-20210327_g16.jpg	Edgar Link	pending
intc-20210327_g17.jpg	Edgar Link	pending
intc-20210327_g18.jpg	Edgar Link	pending
intc-20210327_g19.jpg	Edgar Link	pending
intc-20210327_g2.jpg	Edgar Link	pending
intc-20210327_g20.jpg	Edgar Link	pending
intc-20210327_g21.jpg	Edgar Link	pending
intc-20210327_g22.jpg	Edgar Link	pending
intc-20210327_g23.jpg	Edgar Link	pending
intc-20210327_g3.jpg	Edgar Link	pending
intc-20210327_g4.jpg	Edgar Link	pending
intc-20210327_g5.jpg	Edgar Link	pending
intc-20210327_g6.jpg	Edgar Link	pending
intc-20210327_g7.jpg	Edgar Link	pending
intc-20210327_g8.jpg	Edgar Link	pending
intc-20210327_g9.jpg	Edgar Link	pending
intc-20210327_htm.xml	Edgar Link	completed
intc-20210327_lab.xml	Edgar Link	unprocessable
intc-20210327_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INTC
Intel Corp Stock $intc

2021 Q1 Form 10-Q Financial Statement

#000005086321000018 Filed on April 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INTC Intel Corp Stock $intc

2021 Q1 Form 10-Q Financial Statement

#000005086321000018 Filed on April 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INTC
Intel Corp Stock $intc